Biopharmaceutical Analysis & Statistics, January 2013 (p7)

24/7 Customer Support

Talk to Clare

+1 339 368 6001

Publishers

All regions

You might be interested in: Protein, Biomedical, Antibody, more »

181-220 of about 900 reports

Purchase Reports From Reputable Market Research Publishers

Immuron Limited (IMC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Immuron Limited (IMC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2014
  • by Global Data

Summary Immuron Limited (Immuron) is a biopharmaceutical company. The company conducts research and develops polyclonal antibody products for humans. Its products include Travelan, IMM-272, IMM 124-E, ...

  • Industries : Biopharmaceutical
Gene Techno Science Co., Ltd. (4584) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Gene Techno Science Co., Ltd. (4584) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2014
  • by Global Data

Summary Gene Techno Science Co., Ltd. (GTS) is a biotechnology company. The company develops and markets drug and antibodies for intractable diseases and rare diseases. Its products include GND-001, GND-002, ...

  • Industries : Biopharmaceutical
PharmAthene, Inc. (PIP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

PharmAthene, Inc. (PIP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2014
  • by Global Data

Summary PharmAthene, Inc. (PharmAthene) is a pharmaceutical company. The company develops and commercializes medical counter measures to biological and chemical weapons. Its products include recombinant ...

  • Industries : Biopharmaceutical
  • Countries : United States
TapImmune Inc. (TPIV) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

TapImmune Inc. (TPIV) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2014
  • by Global Data

Summary TapImmune Inc. (TapImmune) is a biotechnology company. The company develops peptide and gene-based immunotherapeutics and vaccines for the treatment of oncology and infectious disease. Its immunotherapy ...

  • Industries : Biopharmaceutical
  • Countries : United Kingdom, United States
UMN Pharma Inc. (4585) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

UMN Pharma Inc. (4585) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2014
  • by Global Data

Summary UMN Pharma Inc. (UMN) is a biopharmaceutical company. The company develops vaccines to cure diabetes, muscular dystrophy and influenza. Its products include UMN-0502, UMN-0501, UMN-0901 and UMN-2003. ...

  • Industries : Biopharmaceutical
Versartis, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Versartis, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2014
  • by Global Data

Summary Versartis, Inc. (Versartis) is a biopharmaceutical company. It develops therapeutic proteins for the treatment of endocrine disorders. The company's product pipeline includes VRS-317, a human growth ...

  • Industries : Biopharmaceutical
  • Countries : United States
Viropro Inc. (VPRO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Viropro Inc. (VPRO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2014
  • by Global Data

Summary Viropro, Inc. (Viropro) is a pharmaceutical company. The company develops and manufactures therapeutic monoclonal antibodies. Its products include Rituximab, Trastuzumab, Infliximab, Etanercept ...

  • Industries : Biopharmaceutical
  • Countries : United States
Merger & Acquisition in Medical Equipment Industry: QuantRx Biomedical Corporation (QTXB)

Merger & Acquisition in Medical Equipment Industry: QuantRx Biomedical Corporation (QTXB)

  • $ 250
  • Company report
  • July 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : United States
Antibodies in Oncology Drug Pipeline Update 2014

Antibodies in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

The commercial and therapeutic success of antibodies like Rituxan, Avastin, and Erbitux will force the industry to look into the next generation of therapeutic antibodies, preparing themselves for the ...

  • Industries : Biopharmaceutical
Antibodies in Oncology: Drug Pathway Analyzer 2014

Antibodies in Oncology: Drug Pathway Analyzer 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

Extra value: One year of free online updates included with this product There are today at least 608 antibody drugs known to affect more than 206 specific intracellular signaling pathways for the treatment ...

  • Industries : Biopharmaceutical
Sports Nutrition Market Analysis in Taiwan

Sports Nutrition Market Analysis in Taiwan

  • $ 898
  • Industry report
  • July 2014
  • by Euromonitor International

With economic recovery from the second half of 2009, sales of sports nutrition products increased, and in 2010 saw 2% growth in current value terms. Euromonitor International's report offers a comprehensive ...

  • Industries : Sport Nutritional, Biopharmaceutical
  • Countries : Taiwan
Sanofi SA - Strategy and SWOT Report

Sanofi SA - Strategy and SWOT Report

  • $ 175
  • Company report
  • July 2014
  • by MarketLine

Sanofi SA - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate ...

  • Industries : Biopharmaceutical
  • Countries : France
Mabion SA (MAB) - Financial and Strategic SWOT Analysis Review

Mabion SA (MAB) - Financial and Strategic SWOT Analysis Review

  • $ 125
  • Company report
  • July 2014
  • by Global Data

Mabion SA (MAB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to ...

  • Industries : Biopharmaceutical
  • Countries : Iceland
Sports Nutrition Market Overview in Brazil

Sports Nutrition Market Overview in Brazil

  • $ 898
  • Industry report
  • July 2014
  • by Euromonitor International

Creatine was released by ANVISA (Health Surveillance Agency) to be sold as sport nutrition in May 2010. Prior to that, creatine was classified a medicine by ANVISA and sports nutrition manufacturers had ...

  • Industries : Sport Nutritional, Biopharmaceutical
  • Countries : Brazil
Vaccine Partnering Terms and Agreements

Vaccine Partnering Terms and Agreements

  • $ 2 995
  • Industry report
  • July 2014
  • by Currentpartnering

The Vaccine Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the vaccine partnering deals and agreements entered into by the worlds leading healthcare ...

  • Industries : Biopharmaceutical
  • Countries : United States
Sports Nutrition Market Analysis in New Zealand

Sports Nutrition Market Analysis in New Zealand

  • $ 898
  • Industry report
  • July 2014
  • by Euromonitor International

This is evident in 2010’s growth of 1%, being lower than the review period CAGR of 4%. Euromonitor International's report offers a comprehensive guide to the size and shape of the industry at a national ...

  • Industries : Sport Nutritional, Biopharmaceutical
  • Countries : New Zealand
Advances in Enzyme Technology for the Food Industry

Advances in Enzyme Technology for the Food Industry

  • $ 240
  • Industry report
  • July 2014
  • by Food Tech. Intelligence

Food Technology Intelligence, Inc. offers a revised and updated in-depth report analyzing several new developments in enzyme research. The report will give you a first-hand look at many commercially-viable ...

  • Industries : Biopharmaceutical, Agriculture
Glucagon-Like Peptide 2 (GLP-2) Agonists -Pipeline Insights, 2014

Glucagon-Like Peptide 2 (GLP-2) Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

  • Industries : Biopharmaceutical
Heat Shock Protein 27 (Hsp27) Inhibitors -Pipeline Insights, 2014

Heat Shock Protein 27 (Hsp27) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

  • Industries : Biopharmaceutical
Heat Shock Protein 70 (Hsp70) Inhibitors -Pipeline Insights, 2014

Heat Shock Protein 70 (Hsp70) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

  • Industries : Biopharmaceutical
Insulin Like Growth Factor 2 (IGF-2) Inhibitors -Pipeline Insights, 2014

Insulin Like Growth Factor 2 (IGF-2) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

  • Industries : Biopharmaceutical
Protein Kinase C Beta (PKC-Beta) Inhibitors -Pipeline Insights, 2014

Protein Kinase C Beta (PKC-Beta) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

  • Industries : Biopharmaceutical
Protein-Tyrosine Phosphatase 1B (PTP1B) Inhibitors -Pipeline Insights, 2014

Protein-Tyrosine Phosphatase 1B (PTP1B) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

  • Industries : Biopharmaceutical
Tumor Necrosis Factor Alpha (TNF-a) Agonists -Pipeline Insights, 2014

Tumor Necrosis Factor Alpha (TNF-a) Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

  • Industries : Biopharmaceutical
5-Lipoxygenase Activating Protein (FLAP) Inhibitors -Pipeline Insights, 2014

5-Lipoxygenase Activating Protein (FLAP) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“5-Lipoxygenase Activating Protein (FLAP) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). ...

  • Industries : Biopharmaceutical
Alpha2beta1 Integrin Antagonists (Very Late Antigen 2 (VLA-2) -Pipeline Insights, 2014

Alpha2beta1 Integrin Antagonists (Very Late Antigen 2 (VLA-2) -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Alpha2beta1 Integrin Antagonists (Very Late Antigen 2 (VLA-2)-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of ...

  • Industries : Biopharmaceutical
AMP Activated Protein Kinase (AMPK) Inhibitors -Pipeline Insights, 2014

AMP Activated Protein Kinase (AMPK) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“AMP Activated Protein Kinase (AMPK) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A ...

  • Industries : Biopharmaceutical
Amyloid Protein Blockers -Pipeline Insights, 2014

Amyloid Protein Blockers -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Amyloid Protein Blockers-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the ...

  • Industries : Biopharmaceutical
Anti-CD105 Antibody -Pipeline Insights, 2014

Anti-CD105 Antibody -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Anti-CD105 Antibody-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report ...

  • Industries : Biopharmaceutical
Anti-CD152 Antibody -Pipeline Insights, 2014

Anti-CD152 Antibody -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Anti-CD152 Antibody-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report ...

  • Industries : Biopharmaceutical
About 900 reports

Download Unlimited Documents from Trusted Public Sources

Biopharmaceutical Industry - Analyst Report, October 2014

  • Small-cap Research
  • October 2014
    8 pages
  • Drug And Medica...  

    Vaccine  

  • United States  

View report >

Antigen Market

September 2014

29 Companies

Read our Company Profiles

Johnson and Johnson

United States

Biogen Idec

United States

GlaxoSmithKline P.L.C.

United States

Abbott Laboratories

United States

Merck KGaA

Germany

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.